Key result
Direct injection of a plasmid vector expressing hIL-1Ra improved 14-day survival to 77% compared to 30% with empty vector in mice with experimental coxsackieviral myocarditis.
Why the study?
Does direct injection of a plasmid vector expressing hIL-1Ra improve survival in a mouse model of coxsackieviral myocarditis?
Does direct injection of a plasmid vector expressing hIL-1Ra improve survival in a mouse model of coxsackieviral myocarditis?
Local expression of hIL-1Ra via plasmid DNA injection improves survival and reduces myocardial inflammation in a murine model of viral myocarditis.
Answers are grounded in this paper and cite their sources.
IL-1Ra gene therapy merits human translation studies in viral myocarditis; leaves open clinical efficacy and safety.
BACKGROUND: The inflammatory cytokines have an important role in the pathogenesis of viral myocarditis. Inerleukin-1 (IL-1) is one of the major cytokines that modulate the outcome of viral infection. Among the methods for in vivo gene transfer, direct injection of plasmid DNA is one that is simple and feasible. In this study, we expressed human IL-1 receptor antagonist (hIL-1Ra) in the mouse heart by direct injection of a novel plasmid vector and evaluated its effects on coxsackieviral (CVB3) myocarditis. METHODS AND RESULTS: A plasmid vector expressing hIL-1Ra (total 40 microg/mouse) was injected into the heart apex of 8-week-old inbred female Balb/C mice (day 3). On day 0, mice (IL-1Ra-CVB3, n=35) were infected intraperitoneally with 10(4) PFU of CVB3; control mice (pCK-CVB3, n=15) were injected with empty vector on day -3 and infected on day 0. hIL-1Ra was expressed in the heart, reached its peak on day 5, and persisted for 2 weeks. The 14-day survival rate of IL-1Ra-CVB3 was higher (77%) than that of controls (30%, P<0.01). Myocardial virus titers on day 3 were lower in IL-1Ra-CVB3 mice. Myocardial inflammation on day 7 and fibrosis on day 14 were markedly decreased in IL-1Ra-CVB3. CONCLUSION: These results showed that direct injection of the expression plasmid vector into the heart was an effective method to transfer the cytokine gene in vivo, and expressed IL-1Ra in the heart can modulate the deleterious effect of the host immune response in viral myocarditis.
No takes yet. Share an insight, caveat, or question.
Lim et al. (2002) studied coxsackieviral (CVB3) myocarditis (n=50). plasmid vector expressing human IL-1 receptor antagonist (hIL-1Ra) vs. empty vector was evaluated on 14-day survival rate (p=<0.01). Direct injection of a plasmid vector expressing hIL-1Ra improved 14-day survival to 77% compared to 30% with empty vector in mice with experimental coxsackieviral myocarditis.
Synapse has enriched 10 related papers. Consider them for comparative context: